⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Serán BioScience and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Serán BioScience
↗Bend, Oregon, USA
Serán BioScience is a science-driven Contract Development and Manufacturing Organization (CDMO) that specializes in drug development, formulation, and clinical manufacturing. The company is recognized for its expertise in solving complex drug delivery challenges, particularly for poorly soluble compounds, utilizing technologies such as spray drying, hot melt extrusion, and nano-milling.
Founded in 2016 and headquartered in Bend, Oregon, Serán provides integrated services from discovery through to clinical and early commercial supply. The company is currently expanding its infrastructure, including the development of a new commercial-scale manufacturing campus to support the growing needs of pharmaceutical and biotechnology clients.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Revenue:$100M-$250M
Founded:2016
Ownership:private
Status:operating
FUNDING
Stage:Venture
Total Raised:$200M+
Investors:Bain Capital Life Sciences, Vivo Capital, Foresite Capital, OrbiMed
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Modalities:Small molecule, Proteins, Peptides
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Pharmaceutical and biotechnology companies (client-based partnerships)
COMPETITION
Position:Emerging
Competitors:Lonza, Catalent, Patheon (Thermo Fisher), Alcami
LEADERSHIP
Key Executives:
Dan Smithey - CEO & Co-Founder
Rod Ketner - VP of Business Operations
Jeffrey Evans - Sr. Vice President of Operations
Scientific Founders:Dan Smithey
Board Members:Kevin Nepveux, Will Cozean
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Serán BioScience. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.